Literature DB >> 16356787

Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.

Neil E Alexis1, Marianne S Muhlebach, David B Peden, Terry L Noah.   

Abstract

BACKGROUND: Recent reports suggest that endotoxin exposure can blunt phagocyte functions. The aim of this study was to examine whether lung phagocytic cells have altered host defense function in young cystic fibrosis (CF) patients, and to explore the contribution of neutrophil elastase (NE) and surfactant proteins to these effects.
METHODS: BALF cells from CF children (N=12) and disease controls (N=12) were analyzed by flow cytometry for mCD14 and HLA-DR expression and phagocytosis. The effects of exogenous surfactant protein A and D (SP-A,D) and proteases on BALF cells in short term culture were assessed experimentally.
RESULTS: Expression of the surface markers mCD14 and HLA-DR, and phagocytosis, were all blunted on CF phagocytes compared to disease controls (p<0.05). In CF phagocytes, SP-A enhanced both phagocytosis and mCD14 expression (p<0.05). Both CF BALF and NE reduced phagocytosis and expression of mCD14 and HLA-DR (p<0.05) by non-CF phagocytes; the latter effect was attenuated by protease inhibitor.
CONCLUSION: CF airway phagocytes appear to have altered host defense functions that could contribute to poor bacterial clearance. These impairments can be reproduced by incubation of non-CF cells with NE, while SP-A can partially reverse them. Decreasing protease activity and increasing collectin activity may be beneficial in early CF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356787      PMCID: PMC1764441          DOI: 10.1016/j.jcf.2005.11.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  39 in total

1.  Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia.

Authors:  Steven G Muehlstedt; Mark Lyte; Jorge L Rodriguez
Journal:  Shock       Date:  2002-06       Impact factor: 3.454

2.  Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance.

Authors:  Kerstin Wolk; Stefanie Kunz; Nigel E A Crompton; Hans-Dieter Volk; Robert Sabat
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

Review 3.  Inflammation in cystic fibrosis and its management.

Authors:  G Döring; D Worlitzsch
Journal:  Paediatr Respir Rev       Date:  2000-06       Impact factor: 2.726

Review 4.  Animal models of cystic fibrosis.

Authors:  Bob J Scholte; Donald J Davidson; Martina Wilke; Hugo R De Jonge
Journal:  J Cyst Fibros       Date:  2004-08       Impact factor: 5.482

Review 5.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

6.  Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.

Authors:  R William Vandivier; Carol Anne Ogden; Valerie A Fadok; Peter R Hoffmann; Kevin K Brown; Marina Botto; Mark J Walport; James H Fisher; Peter M Henson; Kelly E Greene
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

Authors:  Matthias Griese; Robert Essl; Reinhold Schmidt; Ernst Rietschel; Felix Ratjen; Manfred Ballmann; Karl Paul
Journal:  Am J Respir Crit Care Med       Date:  2004-07-21       Impact factor: 21.405

8.  Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.

Authors:  Terry L Noah; Paula C Murphy; Jorien J Alink; Margaret W Leigh; William M Hull; Mildred T Stahlman; Jeffrey A Whitsett
Journal:  Am J Respir Crit Care Med       Date:  2003-06-26       Impact factor: 21.405

9.  Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease.

Authors:  F Rubio; J Cooley; F J Accurso; E Remold-O'Donnell
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

10.  Ultrastructure and function of alveolar macrophages from cystic fibrosis patients.

Authors:  M J Thomassen; C A Demko; R E Wood; B Tandler; D G Dearborn; B Boxerbaum; P J Kuchenbrod
Journal:  Pediatr Res       Date:  1980-05       Impact factor: 3.756

View more
  25 in total

1.  Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.

Authors:  Kim Thomsen; Lars Christophersen; Peter Østrup Jensen; Thomas Bjarnsholt; Claus Moser; Niels Høiby
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 2.  Update in Cystic Fibrosis 2018.

Authors:  Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

Review 3.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

4.  Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

Authors:  Frank H Robledo-Avila; Juan de Dios Ruiz-Rosado; Kenneth L Brockman; Benjamin T Kopp; Amal O Amer; Karen McCoy; Lauren O Bakaletz; Santiago Partida-Sanchez
Journal:  J Immunol       Date:  2018-08-17       Impact factor: 5.422

5.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

6.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19

Review 7.  Cystic Fibrosis: Microbiology and Host Response.

Authors:  Edith T Zemanick; Lucas R Hoffman
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

8.  Effects of ex vivo γ-tocopherol on airway macrophage function in healthy and mild allergic asthmatics.

Authors:  Marianne Geiser; John C Lay; William D Bennett; Haibo Zhou; Xiaoyan Wang; David B Peden; Neil E Alexis
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

9.  Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.

Authors:  Stefanos Voglis; Kieran Quinn; Elizabeth Tullis; Mingyao Liu; Melanie Henriques; Celia Zubrinich; Oscar Peñuelas; Holman Chan; Frances Silverman; Vera Cherepanov; Neil Orzech; Aye Aye Khine; André Cantin; Arthur S Slutsky; Gregory P Downey; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2009-04-30       Impact factor: 21.405

10.  Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.

Authors:  Isabel Vega-Carrascal; David A Bergin; Oliver J McElvaney; Cormac McCarthy; Nessa Banville; Kerstin Pohl; Mitsuomi Hirashima; Vijay K Kuchroo; Emer P Reeves; Noel G McElvaney
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.